TEVA Core Challenges Aren’t Going To Fade Anytime Soon, Says Analyst
As the healthcare community debates the positive top line results from Alkermes Plc (NASDAQ:ALKS) FORWARD-5 study for ALKS 5461 in major depressive disorder, Credit Suisse analyst …
